Measurement of Mass Change in Serum Albumin Compared to Serum Lactic Acid as Predictive Tool for Sepsis Prognosis in Non Surgical ICU Patients
Condition(s) studied
Investigational drug(s) / intervention(s)
Mass change in serum albumin: study aims to assess the accuracy of measurement of mass change in serum albumin compared to serum lactic acid as predictive tool for sepsis prognosis in nonsurgical ICU patients
Study summary
This study aims to assess the reliability of measurement of mass change in serum albumin compared to serum lactic acid as predictive tool for sepsis prognosis in nonsurgical ICU patients
Eligibility
Primary outcome measure(s)
- Comparative value between mass change in serum albumin and serum lactate in prediction of sepsis prognosis (discharge or mortality) — 12 months
Knowing Which is more accurate in predicting the prognosis of sepsis between mass change in serum albumin and serum lactic acid in non surgical icu patients
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Hospitals ofAin shams university | Cairo | Elabasya |
More Ain Shams University trials in Egypt
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07289906 on ClinicalTrials.gov ↗ ← All trials in Egypt